Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Stock Information for Immuron Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Immuron Limited

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now
Immuron Travelan® continued strong sales growth
Immuron Announces Travelan® Clinical Trial Update
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.